<PAGE> 1
================================================================================
- --------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): MAY 3, 1996
N-VIRO INTERNATIONAL CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)
DELAWARE 0-21802 34-1741211
(STATE OR OTHER JURISDICTION (COMMISSION (IRS EMPLOYER
OF INCORPORATION) FILE NUMBER) IDENTIFICATION NO.)
3450 W. CENTRAL AVENUE, SUITE 328
TOLEDO, OHIO 43606
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (419) 535-6374
- --------------------------------------------------------------------------------
================================================================================
<PAGE> 2
ITEM 2. ACQUISITION AND DISPOSITION OF ASSETS
On May 3, 1996, N-Viro International Corporation agreed to an asset sale
of its wholly owned subsidiary, BioCheck Laboratories, Inc. to Laboratory
Resources, Inc., Toledo, Ohio. Under the terms of this sale, N-Viro
International Corporation retains certain assets and leases laboratory
equipment to Laboratory Resources, Inc. In turn, Laboratory Resources, Inc.
agrees to perform specific quality control and alkaline admixture testing for
N-Viro International Corporation and will operate under the tradename of Bio
Check Labs.
N-Viro International Corporation anticipates the completion of this sale
within this fiscal quarter, ending June, 30, 1996. Laboratory Resources, Inc.,
is a company owned and managed by the former employees of BioCheck
Laboratories, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
N-VIRO INTERNATIONAL CORPORATION
Dated: May 15, 1996 By: /s/ John R. Kolpien
-------------- --------------------
John R. Kolpien
Chief Financial Officer
